We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

NYT:NYSENew York Times Company (The) Analysis

Data as of 2026-05-19 - not real-time

$76.68

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

The New York Times Company posted a robust Q1 with revenue climbing 12% YoY to $712 million and non‑GAAP earnings per share beating expectations by over 30%, underscoring the strength of its subscription‑driven model. Operating margins remain healthy at roughly 13% and cash flow generation is solid, supporting a sustainable dividend yield of about 1.2% with a payout ratio under 45%. However, the stock trades at a trailing P/E of 33x—nearly double the industry average—while a discounted cash‑flow analysis suggests a fair value around $56, indicating a significant premium to intrinsic value. Technicals are mixed: the price sits just above the 200‑day SMA but below the 20‑ and 50‑day averages, the MACD is bearish and RSI hovers near the midpoint, with the market testing a support level near $74. Volume is rising, reflecting investor interest despite heightened volatility (≈38% over 30 days) and an “Extreme Greed” sentiment reading.
Given the strong earnings momentum, growing digital subscriber base, and modest debt profile, the company offers a compelling growth narrative, yet the current valuation appears stretched. Investors should weigh the near‑term technical weakness and elevated valuation against the longer‑term upside potential from continued subscription expansion and dividend stability.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Recent earnings beat fuels short‑term optimism
  • Price hovering near support with bearish MACD
  • Rising volume indicates active trading

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Sustained revenue growth and subscriber expansion
  • Analyst consensus of Buy with target upside ~9‑10%
  • Stable dividend and strong cash flow generation

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Durable brand and digital subscription moat
  • Solid return on equity and low beta reducing market risk
  • Dividend sustainability supporting total return

Key Metrics & Analysis

Financial Health

Revenue Growth12.10%
Profit Margin13.30%
P/E Ratio32.9
ROE19.68%
ROA10.45%
Debt/Equity2.39
P/B Ratio6.2
Op. Cash Flow$577.6M
Free Cash Flow$396.8M
Industry P/E17.2

Technical Analysis

TrendNeutral
RSI44.2
Support$74.11
Resistance$87.00
MA 20$78.80
MA 50$80.52
MA 200$68.40
MACDBearish
VolumeIncreasing
Fear & Greed Index89.34

Valuation

Fair Value$56.48
Target Price$84.00
Upside/Downside9.55%
GradeOvervalued
TypeGrowth
Dividend Yield1.20%

Risk Assessment

Beta0.32
Volatility38.19%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.